Hey I understand your concern and I too would like to know the exact timing, but unfortunately when you are dealing with the FDA there are many variables. As I said earlier they have to meet certain criteria before they can launch. I would much rather have them take the time to get everything right and be within the FDA guidelines before launching ForFivo XL. It is not always as easy as it seems.
I remember when we were already to launch Prilosec OTC when the FDA had concerns over the labeling and the launch was delayed by 3 months. It is very rare for any pharma company to give an exact date for a launch until everything has met all the FDA guidelines.
On the other hand it could be an issue related to Edgemonts capabilities and that they require more time to be fully prepared to launch ForFivo XL correctly. If that were the case, then I agree, this should be shared with the investors.
The way it stands now is that we can expect ForFivo XL to be launched late September or early October this year, which is according to the latest pipeline update.
I think at this time it is way too premature to believe that they will have to borrow money or issue stock. I think the only way that would happen would be if ForFivo XL needs to be delayed into next year, which I do not think will happen.
I would expect Mr. Zerbe to communicate directly with his shareholders regarding any further delays or change in timing. I do believe they need to improve their public relations and I hope they make the necessary changes very soon!
I still like the long term prospects for IGXT and I will continue to accumulate shares when feasible. Disclosure: Long IGXT
Cheers!
Market Data 
Markets 
AI
